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Emergency General Surgery (EGS) is an important acute care service, which demands 
significant healthcare resources.1 In Scotland, there were 81,446 EGS admissions involving 
66,498 patients in 2016,2 thus, based on unadjusted population estimates, the UK-wide 
figure may be nearly 1 million annual EGS admissions. National Health Service (NHS) costs 
are increasing,3 while the number of EGS admissions are also increasing over time,4 
associated with an ageing demographic.5 Though several studies have examined population-
based EGS outcomes in Scotland,2,4,6-8 and England,9 no study has evaluated the costs of EGS 
in the UK, with its single-payer National Health Service, or estimated future financial 
burden.  
EGS epidemiology10-11 and cost12-14 are now well-established in the literature in the context 
of the United States (US). In the US, there were an estimated 2.3 million EGS admissions in 
2009,10 and 27.7 million admissions between 2001 and 2010, representing 7.1% of all 
hospital admissions, with a population-adjusted case rate of 1,290 admissions/100,000 
people.11 Furthermore, over the course of a decade, EGS admissions in the US increased by 
27.5% and operations by 32.3%.11 The mean cost per EGS admission in the US (which 
required an operation within 2 days of admission) was $13,241 between 2008 and 2011.12 
Nation-wide costs are projected to increase substantially, by 45%, from $28.4 billion in 2010 
to $41.2 billion by 2060, largely due to an ageing US population.15  
There are major differences in the structure and financing of healthcare between the UK, 
with its single-payer National Health Service, and the United States. The impact of these 
differences on the future financial burden of EGS is important to the public, healthcare 
providers, and decision makers, in both countries. The aim of this study was to calculate the 






Population estimates from 2016 to 2041 were obtained from the National Records of 
Scotland (NRS), overall and for each age group. Estimates obtained included a principal 
projection (best-estimate), a high population estimate (in the event of high fertility, high 
migration and high life expectancy), and a low population estimate (low fertility, low 
migration and low life expectancy).16 
EGS admissions 
Data including all Scottish EGS hospital admissions between 1997 and 2016, coded by ICD-
10 (International Statistical Classification of Diseases and Related Health Problems 10th 
Revision) were obtained from Information Services Division (ISD).4,17 An EGS episode was 
defined as an unplanned (emergency) admission of a patient aged 16 years or older, to a 
Scottish hospital, under the care of a consultant general surgeon.4 A “general surgeon” 
refers to surgeons who hold a “Certificate of Completion of Training” in general surgery, as 
captured by the “C1” specialty code in the database held by the Information Services 
Division of the Scottish Government. Anonymized data were transferred to the Data 
Safehaven (DaSH) of the University of Aberdeen for analysis. Annual EGS admissions were 
determined by our previous work, which examined secular trends in EGS admission rates 
per 100,000 population over a 20-year time period.4 Incidence rates for each sex and age 
group (16-30, 31-45, 46-60, 61-75, >75), for individual conditions and EGS admissions 
overall, were determined and linear regression (using an ordinary least squares [OLS] 
regression model) was used to estimate the future incidence rates of EGS admissions, 
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projected to 2041, using SPSS (IBM Corporation, Armonk, NY). The full model specification is 
provided in Equation 1 (Supplementary Material).  
Length of Hospital Stay 
An OLS linear regression model was initially considered to project historical trends in length 
of hospital stay (LOS) into the future.  This model generated implausible results, as by 2041, 
the length of stay for several age and sex groups fell below zero, reflecting the downward 
trend in observed LOS. Therefore, we used an exponential function, to extrapolate the 
historical trend data for each sex and age group.  The exponential function is advantageous 
because it is the best statistical fit to the historical data, and it generated the most clinically 
plausible future projections, capturing a continuing reduction in LOS, but at a reducing rate 
over time.  The calculations of annual LOS out to 2041 were performed in Excel (Microsoft, 
Redmond, Washington, USA), and the underlying formulae are provided in Equation 2 
(Supplementary Material).  
Cost Per Bed Day 
Historical hospital costs data (unit cost per bed day) were obtained from ISD from 2000 to 
2017,18 and were also projected to 2041, using an OLS linear regression model (Equation 3, 
Supplementary Material). ISD produces a detailed annual document describing costs of 
acute inpatient specialties by hospital, NHS board, and specialty which incorporates the cost 
of nursing, medical, pharmacy, allied healthcare professionals, theatre, laboratory, and 
length of hospital stay. From this, the cost per bed day is derived for each specialty, and we 
have used the value for General Surgery (excluding Vascular Surgery) from 2000 to 2017.18 
The calculation for discounted costs per bed day are shown in supplementary material 
(Equation 4). 
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Projected EGS Cost 
The projected annual cost of EGS admissions was derived from multiplying the expected 
number of EGS admissions (projected population multiplied by admission rate for each age 
and sex group), by the admission cost per patient (projected cost per bed day, multiplied by 
expected LOS for each age and sex group), according to Equation 5 (Supplementary 
Material). The total annual EGS cost was calculated by adding the projected cost of each age 
and sex subgroup for each year. 
Sensitivity analysis 
A range of sensitivity analyses were carried out to test the impact of the base case 
calculation assumptions on total cost projections. 
First, there is uncertainty regarding the impact of future population projections on 
admission rates, and hence costs as the true value will depend on unknown political and 
economic shocks that are as yet unobserved, but may impact on future population 
estimates.  Therefore, the low and high population estimates from National Records for 
Scotland were used in sensitivity analysis to cover the most likely range of future 
possibilities regarding population growth (by age and sex group).16  
Secondly, length of stay projections are heavily influenced by historical trends.  Any future 
constraints on the availability of community and social care that were not observed by the 
last historical data point (2016) would not be accounted for in the exponential 
extrapolations.  For example, the more elderly group in society may not experience a 
reduction in LOS if suitable discharge facilities are not available.  Therefore, we conducted a 
sensitivity analysis where the LOS observed in 2016 remains unchanged into the future for 
each age and sex group, for comparison. 
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Thirdly, the base case analysis projects future costs according to the cost value in the year 
when costs are incurred (“nominal” cost projections).  For example, the projected costs in 
2035 are in 2035 values.  However, as a society, we place less value on costs that occur into 
the future, and one may be indifferent between spending £100 now or £105 in a years’ 
time.  In this case the annual discount rate would be 5%.  To make healthcare decisions, 
decision making bodies such as the National Institute for Health and Care Excellence (NICE) 
consider the time value of money, and make cost-effectiveness decisions based on future 
costs being discounted to present day values.19  To capture the impact of discounting on our 
findings, sensitivity analysis discounts future costs to present values at a rate of 3.5% per 
annum, in accordance with NICE recommendations (“real” cost projections).19 The 





The adult (aged >15) population of Scotland is projected to increase from 4.5 million to 4.8 
million in the principal projection, to 5.1 million in the high projection, and remain 4.5 
million in the low projection (Figure 1, Panel A). Between 2016 and 2041, based on the 
principal, high and low projections, the population of those aged 16-30 will change by -8.0%, 
+0.8%, or -16.2%, with compound annual growth rates (CAGR) of -0.3%, 0.0%, and -0.7%, 
respectively; those aged 31-45 will change by -0.3%, +8.3%, or -9.0% (CAGR 0.0%, 0.3%, -
0.4%), respectively; those aged 46-60 will change by -4.0%, +0.1%, or -8.2% (CAGR -0.2%, 
0.0%, -0.3%), respectively; those aged 61-75 will change by +13.5%, +16.0%, or +10.4% 
(CAGR 0.5%, 0.6%, 0.4%), respectively; and those aged >75 will change by +79.8%, +89.3%, 
or +65.9% (CAGR 2.4%, 2.6%, 2.0%)(Figure 1, Panels B-D). 
EGS Admissions 
EGS admissions projections incorporate the change in population and changes in age- and 
sex-stratified admissions rates. EGS admissions of adults in Scotland are projected to 
increase between 2016 and 2041, from 83 132 adults (>15) to 101 909 in the principal 
projection (+22.6%, CAGR 0.8%), to 108 047 in the high projection (+30.0%, CAGR 1.1%), and 
95 386 in the low projection (+14.7%, CAGR 0.6%), respectively (Figure 2, Panel A). See Table 
1 (Supplementary Material) for age- and sex-specific projections, and CAGR. The number 
and rate of admissions by gender and age group per 100,000 population, as well as the age- 
and sex-standardised rates per 100,000 population, from 1997-2016, using this data has 
been published previously by our group.4 
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Length of Hospital Stay 
By 2041, the mean length of stay of EGS patients, is projected to reduce for each age and 
sex group with the most marked reduction expected to take place in the elderly population: 
LOS in females aged >75 is projected to decrease from 5.1 days in 2016 to 2.0 days in 2041, 
and LOS in males aged >75 from 3.8 days to 1.5 days (Figure 3). 
Cost per Bed Day 
Based on our extrapolations, the undiscounted nominal cost of EGS patients per bed day is 
anticipated to increase from £786 in 2016, to £1534 by 2041 (95.2% 25-year increase, 2.71% 
CAGR), while the undiscounted (real) cost is anticipated to decrease to £695 (11.5% 
decrease, -0.49% CAGR)(Figure 4).  
EGS Cost Projection 
Our primary outcome, the cost of EGS in Scotland projected to 2041, is presented based on 
high, principal and low population projections (Figure 5). Panel A shows the undiscounted 
(nominal) projections, assuming future LOS is determined using an exponential 
extrapolation of historical trends. Panel A shows that from £187.3 million in 2016, the 
projected nominal cost of EGS hospital care for Scottish adults is projected to increase to 
£202.5 million in the principal population projection (CAGR 0.3%), to £214.1 million in the 
high population projection (CAGR 0.5%), and will increase to £189.3 million in the low 
population projection (CAGR 0.0%). 
Sensitivity Analyses 
Figure 5, panel B illustrates the impact of assuming that there are no further decreases in 
average LOS for each age and sex group beyond the mean LOS observed in 2016. Because 
this overall EGS cost equation uses observed LOS in 2016, as opposed to calculated LOS via 
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exponential equations, for each age/gender category, the 2016 values differ. Therefore, 
instead of £187.3 million, the cost for 2016 using observed LOS values is £157.8 million. By 
2041, the total annual nominal cost of EGS care is projected to increase to £398.1 million in 
the principal population projection (CAGR 3.8%), to £418.9 million in the high population 
projection (CAGR 4.0%), and to £373.4 million in the low population projection (CAGR 
3.5%)(Panel B).  
When a 3.5% annual discount rate is applied to represent these future projections in 
present day values, annual discounted (real) costs are projected to be £91.8 million in the 
principal population projection (CAGR -2.8%), £97.0 million in the high population projection 
(CAGR -2.6%), and £85.8 million in the low population projection (CAGR -3.1%)(Figure 5, 
Panel C). Finally, when applying discounting to the assumption that future average LOS will 
remain unchanged from 2016, the real cost by 2041 could equal £180.4 million in the 
principal population projection (CAGR 0.5%), £189.9 million in the high population 
projection (CAGR 0.7%), and £169.2 million in the low population projection (CAGR 




This is the first study to examine the current and projected financial burden of emergency 
general surgery hospital admissions in the context of a single-payer healthcare system, using 
high-quality, population-based, patient-level Scottish data. Given the increasing concerns 
regarding the cost of healthcare, and the impact of different models of funding health 
services, these data are timely. 
We found that the nominal cost of EGS admissions in Scotland’s National Health Service will, 
most likely, increase only modestly, from £187.3 million in 2016 to £202.5 million in 2041, if 
LOS reduction continues. However, discounting to 2016 values, and assuming LOS remains 
static from 2016 figures, EGS cost would be £180.4 million in the principal projection, which 
also increases modestly from £157.8 million and a CAGR of 0.5%. These findings contrast 
sharply with those of Ogola, et al, who calculated that the projected costs (discounted to 
2010 US Dollars) of EGS hospitalizations in the United States – with its insurance-based 
healthcare system – will increase by 45% over the 40 years.15 While health economic studies 
are notoriously difficult to compare, due to variations of healthcare systems, or differences 
in methodology of cost projections,15,20-23 these results provide food for thought. 
Our findings are corroborated by a number of sensitivity analyses, which confirm the 
robustness of our results, to a range of plausible assumptions around population growth 
projections, future trajectory of changes in LOS and the impact of discounting (real) 
projections to present day values. The most striking finding in the population projection is 
that, regardless of the low, principal, or high population projections, the population of those 
aged over 61 years old will dramatically increase between now and 2041. Our data 
projections assume a reduction in the length of stay among all age and sex groups. 
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However, the largest reduction is also predicted to occur in the elderly population. The 
mean LOS of EGS patients for each age and sex group has been decreasing.4 The exponential 
extrapolations fitted to the historic data suggest a continuing reduction in average LOS but 
at a reducing rate over time.  This captures a plateauing effect suggesting that it is unlikely 
that average LOS would fall below 1-2 days in any of the age groups by 2041. These 
exponential projections are used as the primary method because they are the best 
statistical fit to the historical data, and are the most clinically plausible (e.g. compared to a 
linear trend which would suggest negative LOS). This problem of linear future projections of 
LOS resulting in negative values was also identified by Kitazawa, et al, who utilised several 
models including fixed, linear, logarithmic, and a combination of these methods for 
estimation of future prediction.23  
In our study, the latest (2016) mean LOS for each age and sex group are used in sensitivity 
analyses, as well as using discounted (real) values. With no further reduction in LOS, the 
nominal cost may increase to £398.1 million in the principal scenario, with a CAGR of 3.8%. 
Some readers may attribute more worth to this ‘no-change’ LOS, as well as the standard 
discounted (real) values, as a more likely projection scenario, as mentioned above, with EGS 
costing £180.4 million in the principal projection, a modest increase from £157.8 million and 
a CAGR of 0.5%. Finally, in the event that LOS continues to reduce in an exponential 
manner, the discounted (real) cost of EGS is remarkably reduced to £91.8 million (CAGR -
2.8%) in the principal projection. Between 1963 and 2018, Scotland’s Gross Domestic 
Product (GDP) grew at a CAGR of 1.97% {{163 Scottish Government Sept 18, 2019;}}. These 
results indicate that real (discounted) spend growth for EGS service will most likely be 
slower than GDP growth overall. 
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Our results suggest that the nominal cost per bed day will nearly double between 2016 and 
2041. Base case results are undiscounted (nominal), reflecting the projected annual cost 
over time (values in the year that they occur).  As a sensitivity analysis, we explore the 
impact of using a 3.5% annual discount rate to discount (real) future costs to 2018 values.  
The discounting approach is provided for completeness and is in line with NICE 
recommendations for the methods of economic evaluation.19 Recent similar studies have 
discounted costs15 or cost of labour.23 Though undiscounted (nominal) cost per bed day 
increased significantly (CAGR 2.7%), the discounted (real) cost decreased (CAGR -0.5%). For 
comparison, historic GDP for Scotland over the past 55 years, had a CAGR 1.97%.24 The 
annual UK public healthcare expenditure overall may increase from £177.2 billion to 
£314.40 billion (CAGR 2.7%) between 2016 and 2041 using an undiscounted (nominal) 
projection, and decrease to £158.2 billion (CAGR -0.45%) using a 3.5% discounted (real) 
projection.18 
Limitations 
There are several limitations to this study. First, our projection was derived from historical 
data to inform future estimates of Scottish population, EGS admissions, length of hospital 
stay and costs per bed day. Thus, any, as yet unobserved factors that may have a future 
effect on these parameters will impact on the accuracy of the overall projection. It is 
probably unlikely that secular trends of EGS admissions would drastically change between 
the preceding 20 years and the subsequent 20 years, however changes in incidence or in the 
management of certain conditions will have an effect on admissions,4 for example as a 
result of novel evidence or guidelines.  
In addition, this work focuses on inpatient EGS admissions. Although many EGS diagnoses 
necessitate inpatient care, some may not. There are efforts to shift care delivery to 
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substitute inpatient admissions with ‘ambulatory’ services, including ‘surgical assessment 
units’ and ‘emergency day surgery’.25-27 Therefore, our admission projections may 
underestimate future EGS services.  These care episodes may represent a large and 
potentially dramatically growing form of EGS expenditure not captured by this analysis, 
which would nonetheless be of great importance to society and to policy-makers.  
This relates also to our LOS estimates, as continued reduction of LOS is highly dependent on 
whether there is continued migration to non-inpatient care, which may make the sensitivity 
LOS analysis (2016 figures) the most accurate projection. Reductions in length of stay may 
be due to improvements in efficiency of diagnostic tests and imaging, or it may be due to 
recent pressures on the healthcare system which could lead to patients being offered 
discharge home earlier than if there were no pressure for inpatient beds.  The exponential 
extrapolations will reflect this. However, evidence shows that there is a rising incidence of 
patients who are not discharged home,4 and have prolonged stays in hospital due to 
shortages of suitable discharge facilities in the community (for example, rehabilitation, 
nursing homes, hospices, or awaiting occupational therapy interventions in patients’ own 
homes).28 Therefore, the 2016 LOS values may be seen as more accurate for the elderly 
patients in particular, or perhaps the LOS will even increase for this group of patients if 
investment is not allocated for greater community bed capacity.28 Lastly, our results are 
very dependent on the cost per bed day, which includes the cost of staffing, operating 






The spiralling cost of healthcare provision is a major issue. This analysis demonstrates that 
the nominal cost of adult EGS admissions in Scotland’s National Health Service will, most 
likely, increase only modestly, between now and 2041. These findings contrast sharply with 
projections from other settings, and particularly those with insurance-based healthcare 
systems. However, these results are highly dependent on continued reduction in length of 
hospital stay. If length of stay trends were to plateau or increase, especially for elderly 
patients, the cost of EGS would rise dramatically.  
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Figure 1: Scotland’s population projection from 2016-2041. Panel A: Principal, High and Low 
projections. Panel B: Principal projection by age and sex category. Panel C: High population 
projection by age and sex category. Panel D: Low population projection by age and sex 
category. 
Figure 2: Scotland’s EGS admissions projection from 2016-2041. Panel A: EGS admissions 
based on Principal, High and Low population projections. Panel B: EGS admissions based on 
Principal projection by age and sex category. Panel C: EGS admissions based on High 
population projection by age and sex category. Panel D: EGS admissions based on Low 
population projection by age and sex category. 
Figure 3: Projected EGS Mean LOS for each age/sex group. 
Figure 4: Projected EGS Cost per bed day, including undiscounted (nominal) and 3.5% 
discounted (real) values.  
Figure 5: EGS Cost Projections 2016 to 2041, based on projections of population (Principal, 
High, and Low). Panel A: Undiscounted (nominal) and Exponential LOS calculation; Panel B: 
Undiscounted (nominal) and 2016 LOS values; Panel C: 3.5% Discounted (real) and 








Equation 1. Annual EGS Admissions  
Equation 2. Length of Hospital Stay 
Equation 3. Cost per Bed Day 
Equation 4. Discounted (real) Cost per Bed Day  
Equation 5. Projected Annual EGS Cost 
Supplementary Table 1: EGS admissions projection between 2016 and 2041, based on the 
principal, high and low population projections. 
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Figure 1: Scotland’s population projection from 2016-2041. Panel A: Principal, High and Low 
projections. Panel B: Principal projection by age and sex category. Panel C: High population 







Figure 2: Scotland’s EGS admissions projection from 2016-2041. Panel A: EGS admissions 
based on Principal, High and Low population projections. Panel B: EGS admissions based on 
Principal projection by age and sex category. Panel C: EGS admissions based on High 
population projection by age and sex category. Panel D: EGS admissions based on Low 














Figure 5: EGS Cost Projections 2016 to 2041, based on projections of population (Principal, 
High, and Low). Panel A: Undiscounted (nominal) and Exponential LOS calculation; Panel B: 
Undiscounted (nominal) and 2016 LOS values; Panel C: 3.5% Discounted (real) and 







Equation 1. Annual EGS Admissions  
𝑌 =  𝛼 +  𝛽1𝑋1 
Where Y, the dependent variable (number of EGS admissions), is a linear additive function 
of the model constant (𝛼) and (X1), representing the additional effect of each subsequent 
historical year (between 1997 and 2016) on admissions.  The model was used to generate 
future projections of EGS admission rates by multiplying the predicted admissions in any 
given future year (using the estimated co-efficients from Equation 1) by the predicted 
population in that year, divided by 100,000 (to get the rate per 100,000 general population). 
The analyses were repeated separately for each age (16-30, 31-45, 46-60, 61-75, >75) and 
sex (male, female) subgroup in the Scottish adult population. 
 
Equation 2. Length of Hospital Stay 
To enable projections of length of stay into the future, a range of alternative functions were 
explored, fitted to the historical data between the years 1997 and 2016 (linear, exponential, 
logistical, polynomial).  All analyses were fitted in Excel (Microsoft, Redmond, Washington, 
USA).  The trend line that best fit the historical data (based on r squared) and also generated 
sensible future predictions (i.e was always non-negative in the future) was an exponential 
function.  Thus, the exponential trend line function was calculated for each age (16-30, 31-
45, 46-60, 61-75, >75) and sex (male, female) subgroup, and overall. Length of stay (y) in any 
future year X, was calculated using the fitted exponential equation for each subgroup: 
Age Sex LOS equation R squared 
All Adults (>15) All y = 9E+29e
-0.034x 0.94447 
 Male y = 8E+26e
-0.03x 0.9369 
 30 
 Female y = 2E+33e
-0.037x 0.94988 
16-30 All y = 7E+13e
-0.016x 0.67969 
 Male y = 5E+14e
-0.017x 0.76892 
 Female y = 5E+15e
-0.018x 0.68126 
31-45 All y = 7E+21e
-0.025x 0.8784 
 Male y = 7E+19e
-0.022x 0.8678 
 Female y = 3E+24e
-0.028x 0.88235 
46-60 All y = 5E+31e
-0.036x 0.94866 
 Male y = 6E+31e
-0.036x 0.95067 
 Female y = 2E+32e
-0.036x 0.93714 
61-75 All y = 1E+37e
-0.042x 0.95764 
 Male y = 4E+36e
-0.041x 0.9525 
 Female y = 7E+37e
-0.043x 0.95767 
>75 All y = 6E+33e
-0.038x 0.96001 
 Male y = 9E+32e
-0.037x 0.94926 
 Female y = 5E+33e
-0.038x 0.95916 
 
Equation 3. Cost per Bed Day 
𝑌1 =  𝛼 + 𝛽 𝑋1 
Where Y is the dependent variable (cost per bed day of EGS admissions), 𝛼 is the y intercept 
of the model, X1 is the linear additive impact of each subsequent year between 2000 and 
2017 on cost, and 𝛽  is the slope. The rate of cost per bed day change (projected to 2041) 
was calculated in SPSS using the above regression results. In this case, 𝛼 was equivalent to -
59533.051, and 𝛽  was equivalent to £29.92. 
 
Equation 4. Discounted Cost per Bed Day  
𝑌𝑥 =  𝐶𝑥(1 + 𝑟)−(𝑥−2018) 
Where the dependent variable (Y), discounted future cost per bed day, in a given year (x), is 
a linear function of explanatory variables of the cost per bed day (C), multiplied by the 
addition of 1 and the discounted rate (r), to the negative power of the difference between 
 31 
the year (x) minus the index discounted year, which was 2018. The discounted rate (r), was 
assumed to be 3.5% per annum in accordance with national economic evaluation guidelines 
and n represents the number of discount years.19 
 
Equation 5. Projected Annual EGS Cost 
𝐸𝐺𝑆 𝐶𝑜𝑠𝑡𝑥 =  Σ(𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛𝑥𝑗𝑡 ∗ 𝐴𝑑𝑚𝑖𝑠𝑠𝑖𝑜𝑛 𝑅𝑎𝑡𝑒𝑥𝑗𝑡 ∗ 𝐶𝑜𝑠𝑡 𝑃𝑒𝑟 𝐵𝑒𝑑 𝐷𝑎𝑦𝑥 ∗ 𝐿𝑂𝑆𝑥𝑗𝑡)  
Where (x) is the given year, (j) is the given gender, (t) is the given age category (ie males 
aged 16-30). We calculated undiscounted and 3.5% discounted cost projections, and 
incorporated low, principal and high population projections. LOS was calculated as either 
2016 levels for each age/sex group, or calculated using Exponential Trendline function on 




Supplementary Table 1. EGS admissions projection between 2016 and 2041, based on the 













37180 37480 37741 37952 37914 37777 37738 1.5% 0.1% 
  F 47716 50672 54357 58118 61615 65031 65699 37.7% 1.3% 
 16-30 M 6039 5446 4666 4093 3640 3120 3014 -50.1% -2.7% 
  F 9839 10281 10613 11334 12371 13221 13377 36.0% 1.2% 
 31-45 M 6797 6917 7386 7456 7083 6694 6645 -2.2% -0.1% 
  F 8759 9519 11020 11893 12088 12217 12303 40.5% 1.4% 
 46-60 M 8957 8953 8412 8124 8379 9149 9234 3.1% 0.1% 
  F 10738 11353 11307 11498 12342 14003 14221 32.4% 1.1% 
 61-75 M 9238 9640 9940 10228 9830 8809 8640 -6.5% -0.3% 
  F 8732 9457 10314 11281 11512 10882 10786 23.5% 0.8% 
 >75 M 6751 7238 8486 9299 10192 11237 11440 69.5% 2.1% 




37180 37732 38363 38966 39407 39998 40117 7.9% 0.3% 
  F 47716 50985 55176 59536 63830 68520 69481 45.6% 1.5% 
 16-30 M 6039 5522 4798 4237 3809 3388 3300 -45.4% -2.4% 
  F 9839 10441 10956 11780 12989 14383 14673 49.1% 1.6% 
 31-45 M 6797 6974 7567 7797 7563 7259 7221 6.2% 0.2% 
  F 8759 9580 11245 12393 12887 13255 13375 52.7% 1.7% 
 46-60 M 8957 8975 8477 8252 8608 9545 9671 8.0% 0.3% 
  F 10738 11375 11371 11630 12592 14479 14761 37.5% 1.3% 
 61-75 M 9238 9661 9995 10325 9977 9016 8860 -4.1% -0.2% 
  F 8732 9474 10360 11364 11645 11074 10991 25.9% 0.9% 
 >75 M 6751 7279 8603 9524 10573 11842 12098 79.2% 2.4% 




37180 37227 37105 36894 36330 35426 35212 -5.3% -0.2% 
  F 47716 50358 53520 56636 59263 61328 61674 29.3% 1.0% 
 16-30 M 6039 5371 4534 3949 3474 2873 2749 -54.5% -3.1% 
  F 9839 10121 10269 10888 11768 12146 12174 23.7% 0.9% 
 31-45 M 6797 6859 7204 7115 6602 6125 6066 -10.8% -0.5% 
  F 8759 9458 10794 11391 11287 11175 11226 28.2% 1.0% 
 46-60 M 8957 8930 8346 7993 8144 8740 8781 -2.0% -0.1% 
  F 10738 11331 11241 11363 12086 13512 13664 27.3% 1.0% 
 61-75 M 9238 9618 9880 10117 9650 8552 8367 -9.4% -0.4% 
  F 8732 9440 10266 11186 11353 10644 10530 20.6% 0.8% 
 >75 M 6751 7196 8351 9014 9668 10363 10483 55.3% 1.8% 
  F 7993 8312 9293 10017 10934 12056 12278 53.6% 1.7% 
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